Which DMARD for ICI-associated arthritis?

被引：0
|
作者：
Onuora, Sarah
机构：
[1] Nature Reviews Rheumatology,
来源：
NATURE REVIEWS RHEUMATOLOGY | 2023年 / 19卷 / 07期
关键词：
D O I：
10.1038/s41584-023-00983-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In a retrospective study, biologic DMARD therapy was associated with faster control of immune checkpoint inhibitor-associated arthritis but also with a shorter time to cancer progression, compared with methotrexate therapy.
引用
收藏
页码：395 / 395
页数：1
相关论文
共 50 条
  • [21] POLYPHARMACY, ALTHOUGH NOT COMBINATION DMARD THERAPY, IN RHEUMATOID ARTHRITIS IS ASSOCIATED WITH INCREASED HOSPITALISATION RISK
    Filkova, M.
    Ibrahim, F.
    Norton, S.
    Scott, D.
    Mant, T.
    Cope, A.
    Molokhia, M.
    Galloway, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 220 - 221
  • [22] COMORBIDITIES IN RHEUMATOID ARTHRITIS ASSOCIATED WITH DMARD VERSUS BDMARD IN SANTO DOMINGO, DOMINICAN REPUBLIC
    Vasquez, Angelo Alberto Cornelio
    Mora, Teresandris Polanco
    De Heyaime, Jennifer Santana Peralta
    Cruz, Yamilet
    Bautista, Edral Rodriguez
    Lorie, Tirso Valdez
    Imuis, Roberto Munoz
    Feriz, Rafael Alba
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 : S85 - S85
  • [23] PREDICTING WHICH PATIENTS WITH EARLY RHEUMATOID ARTHRITIS WILL CHANGE DMARD DURING THE FIRST 2 YEARS: THE ERAN COHORT
    McWilliams, Dan
    Kiely, Patrick D.
    Young, Adam
    Walsh, David A.
    RHEUMATOLOGY, 2012, 51 : 137 - 137
  • [24] Combination DMARD therapy for rheumatoid arthritis. Full or low DMARD doses? Reply
    ODell, JR
    ANNALS OF THE RHEUMATIC DISEASES, 1997, 56 (05) : 337 - 337
  • [25] TACROLIMUS IN RHEUMATOID ARTHRITIS: A SAFE AND EFFECTIVE DMARD
    Dutta, Shouma
    Breslin, Anne
    Ahmad, Yasmeen
    RHEUMATOLOGY, 2010, 49 : I93 - I93
  • [26] Adherence to biologic DMARD therapies in rheumatoid arthritis
    Koncz, Tamas
    Pentek, Marta
    Brodszky, Valentin
    Ersek, Katalin
    Orlewska, Ewa
    Gulacsi, Laszlo
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (09) : 1367 - 1378
  • [27] Spironolactone As a Novel DMARD in Rheumatoid Arthritis.
    Verma, Inderjeet
    Krishan, Pawan
    Syngle, Ashit
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S639 - S640
  • [28] WHICH CONVENTIONAL DMARD TO SELECT IN THE TREATMENT OF PSORIATIC ARTHRITIS (PSA)? DATA FROM NOR-DMARD ON 1351 TREATMENT COURSES WITH METHOTREXATE (MTX), SULFASALAZINE (SSZ) AND LEFLUNOMIDE (LEF)
    Lie, E.
    Fagerli, K. M.
    Rodevand, E.
    Kalstad, S.
    Mikkelsen, K.
    Wierod, A.
    van der Heijde, D.
    Kvien, T. K.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 670 - 671
  • [29] Functional improvement after patients with rheumatoid arthritis start a new disease modifying antirheumatic drug (DMARD) associated with frequent changes in DMARD: The CORRONA database
    Ranganath, Veena K.
    Paulus, Harold E.
    Onofrei, Alina
    Khanna, Dinesh
    Reed, George
    Elashoff, David A.
    Kremer, Joel M.
    Furst, Daniel E.
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (10) : 1966 - 1971
  • [30] Osteoporosis and rheumatoid arthritis, which nutritional factors are associated?
    Sarkis, K. S.
    Silva, R. G.
    Zerbini, C. F.
    Pinheiro, M. M.
    Martini, L. A.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S474 - S474
12345